BioGaia signs exclusive agreement in Australia
BioGaia has extended its global collaboration with Nestlé by signing an agreement with Nestlé Australia Ltd for the exclusive rights to sell BioGaia Protectis drops in Australia from 2017. The product will be co-branded under the BioGaia and Nestlé brands.
“This exclusive agreement represents another positive development in the global partnership between Nestlé and BioGaia. The product is a natural extension to our existing portfolio, and further strengthens our nutritional offering across the crucial first 1000 days of an infant’s life. This launch signifies the beginning of what we are sure will be a long and successful partnership”, says Angela Lu, Business Executive Officer, Nestlé Infant Nutrition Oceania.
The Asia Pacific region, with Australia as one of its top markets, is one of the largest international probiotic markets and analysts predict that this region will retain its leading position in upcoming years.
BioGaia Probiotic Drops, as the product will be called in Australia, are planned to be launched mid 2017. Today the drops are sold in 70 countries worldwide.
“I am very happy that we have signed this exclusive agreement which further confirms the fruitful collaboration we have with Nestlé. The Australian launch of our Protectis drops, which fits perfectly with Nestlé’s offering, is a great opportunity for us to broaden BioGaia’s reach in the Asia Pacific region”, says Axel Sjöblad, Managing Director, BioGaia.
Latest press releases from BioGaia
2017-02-10 BioGaia AB – Year-end report 2016
2017-01-13 BioGaia’s probiotics to be launched in Thailand
2016-12-07 BioGaia associated MetaboGen starts study on Intrahepatic Cholestasis of Pregnancy with Ferring
For additional information please contact
Axel Sjöblad, Managing Director, BioGaia: 46 8 555 293 00
BioGaia is a healthcare company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri which has probiotic, health- enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap list of the Nasdaq OMX Nordic Exchange Stockholm. www.biogaia.com .
BioGaia AB Box 3242. SE-103 64 STOCKHOLM Street address: Kungsbroplan 3, Stockholm Telephone: 46 8 555 293 00, Corp. identity no. 556380-8723. www.biogaia.com .